Recombinant peroxiredoxin 5 protects against excitotoxic brain lesions in newborn mice

Free Radical Biology and Medicine

Volumn 34, Issue 7, 2003, Pages 862-872

  Plaisant, Frank ^a   Clippe, André ^b   Stricht, Delphine Vander ^b   Knoops, Bernard ^b   Gressens, Pierre ^a  

^a HÔPITAL ROBERT DEBRÉ   (France)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Catalase; Cerebral palsy; Free radicals; Glutamate; N acetylcysteine; N methyl D aspartate; Neuronal cell death; Neuroprotection; Peroxiredoxin

Indexed keywords

ACETYLCYSTEINE; AMPA RECEPTOR; ANTIOXIDANT; BROMINE DERIVATIVE; BROMOWILLARDIINE; CATALASE; DITHIOTHREITOL; IBOTENIC ACID; KAINIC ACID RECEPTOR; MACROGOL; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT; RECOMBINANT PEROXIREDOXIN 5; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN INJURY; BRAIN PROTECTION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; ENZYME ACTIVITY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; MOUSE; NEUROTOXICITY; NEWBORN; NONHUMAN; PERINATAL DEVELOPMENT; PRIORITY JOURNAL; SYSTEMIC THERAPY;

ANIMALIA; EUKARYOTA; MAMMALIA; PROKARYOTA;

EID: 0037376423     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0891-5849(02)01440-5     Document Type: Article

References (64)

1. Hagberg B., Hagberg G., Olow I., van Wendt L. The changing panorama of cerebral palsy in Sweden. VII. Prevalence and origin in the birth year period 1987-90. Acta Paediatr. 85:1996;954-960.
2. Kuban K.C., Leviton A. Cerebral palsy. N. Engl. J. Med. 330:1994;188-195.
3. Inder T.E., Huppi P.S., Warfield S., Kikinis R., Zientara G.P., Barnes P.D., Jolesz F., Volpe J.J. Periventricular white matter injury in the premature infant is followed by reduced cerebral cortical gray matter volume at term. Ann. Neurol. 46:1999;755-760.
4. Peterson B.S., Vohr B., Staib L.H., Cannistraci C.J., Dolberg A., Schneider K.C., Katz K.H., Westerveld M., Sparrow S., Anderson A.W., Duncan C.C., Makuch R.W., Gore J.C., Ment L.R. Regional brain volume abnormalities and long-term cognitive outcome in preterm infants. JAMA. 284:2000;1939-1947.
5. Marin-Padilla M. Developmental neuropathology and impact of perinatal brain damage. III gray matter lesions of the neocortex . J. Neuropathol. Exp. Neurol. 58:1999;407-429.
6. Volpe J. 4th ed Neurology of the newborn. 2001;W.B. Saunders, Philadelphia.
7. Nelson K.B., Ellenberg J.H. Antecedents of cerebral palsy. Multivariate analysis of risk. N. Engl. J. Med. 315:1986;81-86.
8. Dammann O., Leviton A. Role of the fetus in perinatal infection and neonatal brain damage. Curr. Opin. Pediatr. 12:2000;99-104.
9. Johnston M.V. Excitotoxicity in neonatal hypoxia. Ment. Retard. Dev. Disabil. Res. Rev. 7:2001;229-234.
10. Johnston M.V., Trescher W.H., Ishida A., Nakajima W. Neurobiology of hypoxic-ischemic injury in the developing brain. Pediatr. Res. 49:2001;735-741.
11. Inder T., Mocatta T., Darlow B., Spencer C., Volpe J.J., Winterbourn C. Elevated free radical products in the cerebrospinal fluid of VLBW infants with cerebral white matter injury. Pediatr. Res. 52:2002;213-218.
12. Inder T., Mocatta T., Darlow B., Spencer C., Senthilmohan R., Winterbourn C.C., Volpe J.J. Markers of oxidative injury in the cerebrospinal fluid of a premature infant with meningitis and periventricular leukomalacia. J. Pediatr. 140:2002;617-621.
13. Marret S., Mukendi R., Gadisseux J.F., Gressens P., Evrard P. Effect of ibotenate on brain development an excitotoxic mouse model of microgyria and posthypoxic-like lesions . J. Neuropathol. Exp. Neurol. 54:1995;358-370.
14. Redecker C., Hagemann G., Witte O.W., Marret S., Evrard P., Gressens P. Long-term evolution of excitotoxic cortical dysgenesis induced in the developing rat brain. Brain Res. Dev. Brain Res. 109:1998;109-113.
15. Gressens P., Marret S., Hill J.M., Brenneman D.E., Gozes I., Fridkin M., Evrard P. Vasoactive intestinal peptide prevents excitotoxic cell death in the murine developing brain. J. Clin. Invest. 100:1997;390-397.
16. Tahraoui S.L., Marret S., Bodenant C., Leroux P., Dommergues M.A., Evrard P., Gressens P. Central role of microglia in neonatal excitotoxic lesions of the murine periventricular white matter. Brain Pathol. 11:2001;56-71.
17. McDonald J.W., Johnston M.V. Neuroprotective synergism of 2-amino-3-phosphonoproprionate (D,L-AP3) and MK-801 against ibotenate induced brain injury. Neurosci. Lett. 145:1992;213-216.
18. Silverstein F.S., Chen R., Johnston M.V. The glutamate analogue quisqualic acid is neurotoxic in striatum and hippocampus of immature rat brain. Neurosci. Lett. 71:1986;13-18.
19. Acarin L., Gonzalez B., Castellano B., Castro A.J. Microglial response to N-methyl-D-aspartate-mediated excitotoxicity in the immature rat brain. J. Comp. Neurol. 367:1996;361-374.
20. Follett P.L., Rosenberg P.A., Volpe J.J., Jensen F.E. NBQX attenuates excitotoxic injury in developing white matter. J. Neurosci. 20:2000;9235-9241.
21. Dugan L.L., Choi D.W. Excitotoxicity, free radicals, and cell membrane changes. Ann. Neurol. 35:(Suppl):1994;17-21.
22. Volpe J.J. Neurobiology of periventricular leukomalacia in the premature infant. Pediatr. Res. 50:2001;553-562.
23. Martin L.J., Brambrink A.M., Price A.C., Kaiser A., Agnew D.M., Ichord R.N., Traystman R.J. Neuronal death in newborn striatum after hypoxia-ischemia is necrosis and evolves with oxidative stress. Neurobiol. Dis. 7:2000;169-191.
24. Tsuji M., Higuchi Y., Shiraishi K., Kume T., Akaike A., Hattori H. Protective effect of aminoguanidine on hypoxic-ischemic brain damage and temporal profile of brain nitric oxide in neonatal rat. Pediatr. Res. 47:2000;79-83.
25. Tan S., Zhou F., Nielsen V.G., Wang Z., Gladson C.L., Parks D.A. Increased injury following intermittent fetal hypoxia-reoxygenation is associated with increased free radical production in fetal rabbit brain. J. Neuropathol. Exp. Neurol. 58:1999;972-981.
26. Largeron M., Mesples B., Gressens P., Cecchelli R., Spedding M., Le Ridant A., Fleury M. The neuroprotective activity of 8-alkylamino-1,4-benzoxazine antioxidants. Eur. J. Pharmacol. 424:2001;189-194.
27. Marret S., Bonnier C., Raymackers J.M., Delpech A., Evrard P., Gressens P. Glycine antagonist and NO synthase inhibitor protect the developing mouse brain against neonatal excitotoxic lesions. Pediatr. Res. 45:1999;337-342.
28. Rhee S.G., Kang S.W., Chang T.S., Jeong W., Kim K. Peroxiredoxin, a novel family of peroxidases. IUBMB Life. 52:2001;35-41.
29. Hofmann B., Hecht H.J., Flohe L. Peroxiredoxins. Biol. Chem. 383:2002;347-364.
30. Knoops B., Clippe A., Bogard C., Arsalane K., Wattiez R., Hermans C., Duconseille E., Falmagne P., Bernard A. Cloning and characterization of AOEB166, a novel mammalian antioxidant enzyme of the peroxiredoxin family. J. Biol. Chem. 274:1999;30451-30458.
31. Seo M.S., Kang S.W., Kim K., Baines I.C., Lee T.H., Rhee S.G. Identification of a new type of mammalian peroxiredoxin that forms an intramolecular disulfide as a reaction intermediate. J. Biol. Chem. 275:2000;20346-20354.
32. Kropotov A., Sedova V., Ivanov V., Sazeeva N., Tomilin A., Krutilina R., Oei S.L., Griesenbeck J., Buchlow G., Tomilin N. A novel human DNA-binding protein with sequence similarity to a subfamily of redox proteins which is able to repress RNA-polymerase-III-driven transcription of the Alu-family retroposons in vitro. Eur. J. Biochem. 260:1999;336-346.
33. Yamashita H., Avraham S., Jiang S., London R., Van Veldhoven P.P., Subramani S., Rogers R.A., Avraham H. Characterization of human and murine PMP20 peroxisomal proteins that exhibit antioxidant activity in vitro. J. Biol. Chem. 274:1999;29897-29904.
34. Declercq J.P., Evrard C., Clippe A., Stricht D.V., Bernard A., Knoops B. Crystal structure of human peroxiredoxin 5, a novel type of mammalian peroxiredoxin at 1.5 A resolution. J. Mol. Biol. 311:2001;751-759.
35. Wattiez R., Hermans C., Bernard A., Lesur O., Falmagne P. Human bronchoalveolar lavage fluid two-dimensional gel electrophoresis, amino acid microsequencing and identification of major proteins . Electrophoresis. 20:1999;1634-1645.
36. Wang M.X., Wei A., Yuan J., Clippe A., Bernard A., Knoops B., Murrell G.A. Antioxidant enzyme peroxiredoxin 5 is upregulated in degenerative human tendon. Biochem. Biophys. Res. Commun. 284:2001;667-673.
37. Zorumski C.F., Thio L.L., Clifford D.B. Effects of bromowillardiine and willardiine on non-N-methyl-D-aspartate receptors in postnatal rat hippocampal neurons. Mol. Pharmacol. 40:1991;45-51.
38. Patneau D.K., Mayer M.L., Jane D.E., Watkins J.C. Activation and desensitization of AMPA/kainate receptors by novel derivatives of willardiine. J. Neurosci. 12:1992;595-606.
39. Liu T.H., Beckman J.S., Freeman B.A., Hogan E.L., Hsu C.Y. Polyethylene glycol-conjugated superoxide dismutase and catalase reduce ischemic brain injury. Am. J. Physiol. 256:1989;H589-593.
40. He Y.Y., Hsu C.Y., Ezrin A.M., Miller M.S. Polyethylene glycol-conjugated superoxide dismutase in focal cerebral ischemia-reperfusion. Am. J. Physiol. 265:1993;H252-256.
41. Chae H.Z., Uhm T.B., Rhee S.G. Dimerization of thiol-specific antioxidant and the essential role of cysteine 47. Proc. Natl. Acad. Sci. USA. 91:1994;7022-7026.
42. Gressens P., Marret S., Martin J.L., Laquerriere A., Lombet A., Evrard P. Regulation of neuroprotective action of vasoactive intestinal peptide in the murine developing brain by protein kinase C and mitogen-activated protein kinase cascades in vivo and in vitro studies . J. Neurochem. 70:1998;2574-2584.
43. Gressens P., Besse L., Robberecht P., Gozes I., Fridkin M., Evrard P. Neuroprotection of the developing brain by systemic administration of vasoactive intestinal peptide derivatives. J. Pharmacol. Exp. Ther. 288:1999;1207-1213.
44. Dommergues M.A., Patkai J., Renauld J.C., Evrard P., Gressens P. Proinflammatory cytokines and interleukin-9 exacerbate excitotoxic lesions of the newborn murine neopallium. Ann. Neurol. 47:2000;54-63.
45. Laudenbach V., Calo G., Guerrini R., Lamboley G., Benoist J.F., Evrard P., Gressens P. Nociceptin/orphanin FQ exacerbates excitotoxic white-matter lesions in the murine neonatal brain. J. Clin. Invest. 107:2001;457-466.
46. Patkai J., Mesples B., Dommergues M.A., Fromont G., Thornton E.M., Renauld J.C., Evrard P., Gressens P. Deleterious effects of IL-9-activated mast cells and neuroprotection by antihistamine drugs in the developing mouse brain. Pediatr. Res. 50:2001;222-230.
47. Husson I., Mesples B., Bac P., Vamecq J., Evrard P., Gressens P. Melatoninergic neuroprotection of the murine periventricular white matter against neonatal excitotoxic challenge. Ann. Neurol. 51:2002;82-92.
48. de Lima A.D., Merten M.D., Voigt T. Neuritic differentiation and synaptogenesis in serum-free neuronal cultures of the rat cerebral cortex. J. Comp. Neurol. 382:1997;230-246.
49. Tabachnick B.G., Fidell L.S. 3rd ed Using multivariate statistics. 1996;Harper Collins, New York.
50. Dunnett C.W. New tables for mutiple comparaisons with a control. Biometrics. 1964;482-491.
51. Mouzannar R., Miric S.J., Wiggins R.C., Konat G.W. Hydrogen peroxide induces rapid digestion of oligodendrocyte chromatin into high molecular weight fragments. Neurochem. Int. 38:2001;9-15.
52. Back S.A., Gan X., Li Y., Rosenberg P.A., Volpe J.J. Maturation-dependent vulnerability of oligodendrocytes to oxidative stress-induced death caused by glutathione depletion. J. Neurosci. 18:1998;6241-6253.
53. Oka A., Belliveau M.J., Rosenberg P.A., Volpe J.J. Vulnerability of oligodendroglia to glutamate pharmacology, mechanisms, and prevention . J. Neurosci. 13:1993;1441-1453.
54. Cambonie G., Laplanche L., Kamenka J.M., Barbanel G. N-methyl-D-aspartate but not glutamate induces the release of hydroxyl radicals in the neonatal rat modulation by group I metabotropic glutamate receptors . J. Neurosci. Res. 62:2000;84-90.
55. Cambonie G., Kamenka J.M., Barbanel G. Glutamate inhibition of NMDA-induced hydroxyl radical release an ontogenic study in rat . Neuroreport. 12:2001;2035-2039.
56. Sanchez-Alvarez R., Almeida A., Medina J.M. Oxidative stress in preterm rat brain is due to mitochondrial dysfunction. Pediatr. Res. 51:2002;34-39.
57. Halliwell B. Role of free radicals in the neurodegenerative diseases therapeutic implications for antioxidant treatment . Drugs Aging. 18:2001;685-716.
58. Moussaoui S., Obinu M.C., Daniel N., Reibaud M., Blanchard V., Imperato A. The antioxidant ebselen prevents neurotoxicity and clinical symptoms in a primate model of Parkinson's disease. Exp. Neurol. 166:2000;235-245.
59. Buonocore G., Perrone S., Bracci R. Free radicals and brain damage in the newborn. Biol. Neonate. 79:2001;180-186.
60. Baydas G., Karatas F., Gursu M.F., Bozkurt H.A., Ilhan N., Yasar A., Canatan H. Antioxidant vitamin levels in term and preterm infants and their relation to maternal vitamin status. Arch. Med. Res. 33:2002;276-280.
61. Thibeault D.W. The precarious antioxidant defenses of the preterm infant. Am. J. Perinatol. 17:2000;167-181.
62. Haga P., Lunde G. Selenium and vitamin E in cord blood from preterm and full term infants. Acta Paediatr. Scand. 67:1978;735-739.
63. Bracci R., Buonocore G., Talluri B., Berni S. Neonatal hyperbilirubinemia. Evidence for a role of the erythrocyte enzyme activities involved in the detoxification of oxygen radicals. Acta Paediatr. Scand. 77:1988;349-356.
64. Inder T.E., Graham P., Sanderson K., Taylor B.J. Lipid peroxidation as a measure of oxygen free radical damage in the very low birthweight infant. Arch. Dis. Child Fetal Neonatal Ed. 70:1994;F107-F111.